Plaque-type Psoriasis
1 competing product in clinical development for Plaque-type Psoriasis.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| MK-3222 200 mg + MK-3222 100 mg + Placebo to MK-3222 + Placebo to Etanercept + Etanercept 50 mg | Sun Pharmaceutical | Phase 3 | Withdrawn | 32 |